Approximately 188,000 Americans who provided their DNA, medical records, and behavioral surveys to federal scientists as part of the National Institutes of Health’s (NIH’s) All of Us precision medicine project will start to receive the results of the genetic analysis. Genetic information and counseling will be available to all participants, and those whose results show genetic risk factors will be encouraged to take advantage of the latter.
With the All of Us project, which launched in 2017, NIH hopes to eventually capture 1 million participants’ DNA and health data for researchers to access. This repository of data ideally will help investigators identify previously unknown trends and genetic information and allow the medical community to provide personalized health care to patients.
Of the 25,000 participants enrolled in the pilot program, 51% come from racial and ethnic backgrounds that have been historically underrepresented in research and clinical trials.
“There’s no other study, particularly at this scale, that has either sequenced or genotyped so many people and has the diversity that we have, that is now going to responsibly return that information,” said All of Us director Eric Dishman.